Blood plasma replacement solution

摘要

The invention relates to medicine, more specifically the invention relates to pharmaceutical preparations usable for the treatment of severe acute and chronic lesions of a human body, which are the cause of hypovolemia or the alteration of functional properties of a blood with pronounced signs of the immunodeficiency. The invention provides a plasma substitute composition having an immunomodulatmg effect. The invention provides the use of a specific biologically active ingredient agent which is a physiologically acceptable salt of a DNA derivative, preferably a sodium salt obtained from animal raw materials such as a sturgeon or salmon milt. The proposed composition usable in an adjuvant therapy stimulates hematopoiesis and myelopoiesis without any side-effects or complications.